IDEAS home Printed from https://ideas.repec.org/a/eee/respol/v15y1986i1p21-31.html
   My bibliography  Save this article

Schumpeterian innovation and entrepreneurs in capitalism: A case study of the U.S. biotechnology industry

Author

Listed:
  • Kenney, Martin

Abstract

No abstract is available for this item.

Suggested Citation

  • Kenney, Martin, 1986. "Schumpeterian innovation and entrepreneurs in capitalism: A case study of the U.S. biotechnology industry," Research Policy, Elsevier, vol. 15(1), pages 21-31, February.
    • Handle: RePEc:eee:respol:v:15:y:1986:i:1:p:21-31
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/0048-7333(86)90020-X
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Autio, Erkko & Kenney, Martin & Mustar, Philippe & Siegel, Don & Wright, Mike, 2014. "Entrepreneurial innovation: The importance of context," Research Policy, Elsevier, vol. 43(7), pages 1097-1108.
    2. Junfu Zhang, 2006. "A Study of Academic Entrepreneurs Using Venture Capital Data," PPIC Working Papers 2006.01, Public Policy Institute of California.
    3. Roijakkers, Nadine & Hagedoorn, John, 2006. "Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks," Research Policy, Elsevier, vol. 35(3), pages 431-446, April.
    4. Maria Królak & Hanna Górska-Warsewicz & Magdalena Mądra-Sawicka & Krystyna Rejman & Sylwia Żakowska-Biemans & Julita Szlachciuk & Maksymilian Czeczotko & Bartosz Kwiatkowski & Robert Zaremba & Michał , 2022. "Towards Sustainable Innovation in the Bakery Sector—An Example of Fibre-Enriched Bread," Sustainability, MDPI, vol. 14(5), pages 1-19, February.
    5. K. Ramachandran & Sougata Ray, 2006. "Networking and New Venture Resource Strategies," Journal of Entrepreneurship and Innovation in Emerging Economies, Entrepreneurship Development Institute of India, vol. 15(2), pages 145-168, September.
    6. Sergey Filippov & Kálmán Kalotay, 2009. "New Europe’s Promise for Life Sciences," Chapters, in: Wilfred Dolfsma & Geert Duysters & Ionara Costa (ed.), Multinationals and Emerging Economies, chapter 3, Edward Elgar Publishing.
    7. James E. McClure & David Chandler Thomas, 2021. "Schumpeter’s Fatalistic View of Capitalism: How His “Essential” Process of Creative Destruction Survived," Journal of Private Enterprise, The Association of Private Enterprise Education, vol. 36(Summer 20), pages 77-101.
    8. Erik de Bakker & Marc Jeroen Bogaardt & Michiel van der Werff & Volkert Beekman, 2016. "The four legged chair: Benign or detrimental institutional environments for GM crops," FOODSECURE Working papers 54, LEI Wageningen UR.
    9. Shi, Xianwei & Liang, Xingkun & Luo, Yining, 2023. "Unpacking the intellectual structure of ecosystem research in innovation studies," Research Policy, Elsevier, vol. 52(6).
    10. Helen Lawton Smith & Sharmistha Bagchi-Sen & Laurel Edmunds, 2016. "Science, Innovation and Technology Transfer Pathways in Translational Research: A Study of Divergent Trajectories in the Healthcare Sector in Europe," Working Papers 35, Birkbeck Centre for Innovation Management Research, revised Aug 2016.
    11. Steven Casper & Catherine Matraves, 1997. "Corporate Governance and Firm Strategy in the Pharmaceutical Industry," CIG Working Papers FS IV 97-20, Wissenschaftszentrum Berlin (WZB), Research Unit: Competition and Innovation (CIG).
    12. Khoury, Theodore A. & Pleggenkuhle-Miles, Erin G., 2011. "Shared inventions and the evolution of capabilities: Examining the biotechnology industry," Research Policy, Elsevier, vol. 40(7), pages 943-956, September.
    13. Hopkins, Michael M. & Martin, Paul A. & Nightingale, Paul & Kraft, Alison & Mahdi, Surya, 2007. "The myth of the biotech revolution: An assessment of technological, clinical and organisational change," Research Policy, Elsevier, vol. 36(4), pages 566-589, May.
    14. Roijakkers, Nadine & Hagedoorn, John & van Kranenburg, Hans, 2005. "Dual market structures and the likelihood of repeated ties - evidence from pharmaceutical biotechnology," Research Policy, Elsevier, vol. 34(2), pages 235-245, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:respol:v:15:y:1986:i:1:p:21-31. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/respol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.